
Sign up to save your podcasts
Or


BIOLIFE4D is back to tell us more about the technology they are using to create a bioengineered heart! In the United States, there are about 200,000 people who could use a heart transplant to save their lives, but only about 3,500 heart transplants take place each year.
This discrepancy is due to a lack of viable donor hearts. BIOLIFE4D is addressing this problem by developing the technology to create a heart out of the cells of the very patient who will receive the heart for transplantation. Listen in to hear Steven Morris, CEO, and president of BIOLIFE4D, explain how such a heart can be made, why such a method reduces rejection risk, and how it can improve accuracy and ethics in drug testing.
Learn more at www.BIOLIFE4D.com.
By Richard Jacobs4.2
494494 ratings
BIOLIFE4D is back to tell us more about the technology they are using to create a bioengineered heart! In the United States, there are about 200,000 people who could use a heart transplant to save their lives, but only about 3,500 heart transplants take place each year.
This discrepancy is due to a lack of viable donor hearts. BIOLIFE4D is addressing this problem by developing the technology to create a heart out of the cells of the very patient who will receive the heart for transplantation. Listen in to hear Steven Morris, CEO, and president of BIOLIFE4D, explain how such a heart can be made, why such a method reduces rejection risk, and how it can improve accuracy and ethics in drug testing.
Learn more at www.BIOLIFE4D.com.

775 Listeners

382 Listeners

1,877 Listeners

7,245 Listeners

5,003 Listeners

1,531 Listeners

1,923 Listeners

1,724 Listeners

3,496 Listeners

9,292 Listeners

1,106 Listeners

852 Listeners

518 Listeners

295 Listeners

29,338 Listeners